NOTCH2 — Notch Receptor 2

NOTCH2 — Notch Receptor 2

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">NOTCH2 — Notch Receptor 2</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>NOTCH2</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Notch Receptor 2</td>
</tr>
<tr>
<td class="label">Chromosome</td>
<td>1p11</td>
</tr>
<tr>
<td class="label">NCBI Gene</td>
<td><a href="https://www.ncbi.nlm.nih.gov/gene/4853" target="_blank">4853</a></td>
</tr>
<tr>
<td class="label">Ensembl</td>
<td><a href="https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000134250" target="_blank">ENSG00000134250</a></td>
</tr>
<tr>
<td class="label">OMIM</td>
<td><a href="https://omim.org/entry/600275" target="_blank">600275</a></td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/Q12983" target="_blank">Q12983</a></td>
</tr>
<tr>
<td class="label">Diseases</td>
<td>[Alzheimer's Disease](/diseases/alzheimers), [CADASIL](/diseases/cerebral-autosomal-dominant-arteriopathy), Hajdu-Cheney Syndrome</td>
</tr>
<tr>
<td class="label">Expression</td>
<td>Cerebral [cortex](/brain-regions/cortex), [Hippocampus](/brain-regions/hippocampus), Vascular smooth muscle</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">Alzheimer</a>, <a href="/wiki/cancer" style="

NOTCH2 — Notch Receptor 2

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">NOTCH2 — Notch Receptor 2</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>NOTCH2</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Notch Receptor 2</td>
</tr>
<tr>
<td class="label">Chromosome</td>
<td>1p11</td>
</tr>
<tr>
<td class="label">NCBI Gene</td>
<td><a href="https://www.ncbi.nlm.nih.gov/gene/4853" target="_blank">4853</a></td>
</tr>
<tr>
<td class="label">Ensembl</td>
<td><a href="https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000134250" target="_blank">ENSG00000134250</a></td>
</tr>
<tr>
<td class="label">OMIM</td>
<td><a href="https://omim.org/entry/600275" target="_blank">600275</a></td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/Q12983" target="_blank">Q12983</a></td>
</tr>
<tr>
<td class="label">Diseases</td>
<td>[Alzheimer's Disease](/diseases/alzheimers), [CADASIL](/diseases/cerebral-autosomal-dominant-arteriopathy), Hajdu-Cheney Syndrome</td>
</tr>
<tr>
<td class="label">Expression</td>
<td>Cerebral [cortex](/brain-regions/cortex), [Hippocampus](/brain-regions/hippocampus), Vascular smooth muscle</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">Alzheimer</a>, <a href="/wiki/cancer" style="color:#ef9a9a">Cancer</a>, <a href="/wiki/carcinoma" style="color:#ef9a9a">Carcinoma</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">139 edges</a></td>
</tr>
</table>

NOTCH2 — Notch Receptor 2

Pathway / Interaction Diagram

Introduction

NOTCH2 (Notch Receptor 2) encodes a highly conserved transmembrane protein that serves as a critical regulator of cell fate decisions, tissue homeostasis, and developmental processes throughout the nervous and vascular systems. As one of four mammalian Notch receptors (NOTCH1-4), NOTCH2 plays particularly important roles in cerebrovascular development, neurogenesis, oligodendrocyte differentiation, and immune cell maturation. Emerging research has implicated NOTCH2 signaling dysregulation in the pathogenesis of multiple neurodegenerative diseases, including [Alzheimer's disease](/diseases/alzheimers) (AD), cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL), and certain demyelinating disorders. This page provides a comprehensive analysis of NOTCH2 structure, function, signaling mechanisms, and its emerging role in neurodegenerative disease processes.

The Notch Signaling Pathway: An Overview

The Notch signaling pathway represents one of the most evolutionarily conserved intercellular communication mechanisms in multicellular organisms. First discovered in Drosophila melanogaster where notch mutations produced notched wing blades in flies, the pathway has since been implicated in virtually every aspect of embryonic development and adult tissue homeostasis [1](https://pubmed.ncbi.nlm.nih.gov/12455676/). In mammals, the Notch family consists of five ligands (DLL1, DLL3, DLL4, JAG1, and JAG2) and four receptors (NOTCH1-4), each with distinct but overlapping expression patterns and functions.

The canonical Notch signaling pathway operates through a mechanism of direct cell-cell contact. When a Notch receptor on the surface of a signal-receiving cell interacts with its ligand expressed on an adjacent signal-sending cell, a series of proteolytic cleavages are triggered. The first cleavage, catalyzed by ADAM10/ADAM17 metalloproteases, removes the Notch extracellular domain (NECD). This is followed by γ-secretase-mediated intramembranous cleavage that releases the Notch intracellular domain (NICD), which translocates to the nucleus [2](https://pubmed.ncbi.nlm.nih.gov/11940529/). In the nucleus, NICD associates with the transcription factor CSL (CBF1/RBP-Jκ/Su(H)/LAG-1) and co-activators of the Mastermind (MAML) family to regulate expression of downstream target genes, including the Hes and Hey families of basic helix-loop-helix transcription factors.

Beyond canonical signaling, Notch receptors can also signal through non-canonical pathways that involve CSL-independent mechanisms, interactions with other signaling pathways, and ligand-independent activation. This complexity allows Notch signaling to integrate with numerous cellular processes and respond to diverse physiological and pathological contexts.

NOTCH2 Structure and Functional Domains

The NOTCH2 protein is a large type I transmembrane receptor consisting of multiple functional domains that enable its role in signal transduction. The full-length NOTCH2 precursor (approximately 300 kDa) undergoes proteolytic processing in the Golgi apparatus to generate a heterodimeric receptor that is trafficked to the cell surface [3](https://pubmed.ncbi.nlm.nih.gov/14555886/).

The extracellular domain (NECD) of NOTCH2 contains 36 epidermal growth factor-like (EGF) repeats, followed by three LIN-12/Notch repeats (LNR) that participate in autoinhibition. The EGF-like repeats mediate ligand binding and contain specific residues that determine ligand specificity. The LNR domain maintains the receptor in a ligand-bound but inactive state in the absence of appropriate triggering, preventing spurious activation.

The transmembrane domain spans the plasma membrane and houses the site of γ-secretase cleavage (within the transmembrane helix). Following ADAM-mediated shedding of the NECD, the remaining membrane-tethered fragment (NOTCH2ΔE) undergoes conformational changes that enable γ-secretase access to the sc site.

The intracellular domain (NICD2 or NOTCH2^IC) contains multiple functional regions: the RAM domain that mediates high-affinity binding to CSL transcription factors, a series of ankyrin (ANK) repeats that form the transcriptional activation complex, and C-terminal proline-glutamate-serine-threonine (PEST) sequences that regulate protein stability through ubiquitin-mediated degradation. The NICD2 transcriptional program differs somewhat from that of other Notch receptors due to variations in its C-terminal domains and context-specific cofactor interactions.

NOTCH2 Expression in the Central Nervous System

In the adult mammalian brain, NOTCH2 is expressed in multiple neuronal and glial cell populations, with particularly high levels in the [cerebral cortex](/brain-regions/cortex) and [hippocampus](/brain-regions/hippocampus) [4](https://pubmed.ncbi.nlm.nih.gov/15689561/). Neural stem cells and progenitor cells in the subventricular zone and hippocampal subgranular zone express NOTCH2, where it functions to maintain the undifferentiated state and regulate the balance between proliferation and differentiation.

Neurons in the mature brain express NOTCH2 at lower levels, where it participates in synaptic plasticity and maintenance. Studies have demonstrated NOTCH2 localization at synaptic sites, where it can influence dendritic spine morphology and synaptic function [5](https://pubmed.ncbi.nlm.nih.gov/20305642/). The presence of NOTCH2 at excitatory synapses suggests roles in activity-dependent plasticity mechanisms that are central to learning and memory.

In the glial compartment, NOTCH2 plays critical roles in oligodendrocyte development and myelination. Oligodendrocyte precursor cells (OPCs) express NOTCH2, and Notch2 signaling promotes OPC proliferation while inhibiting differentiation—a balance that is dynamically regulated during development and repair [6](https://pubmed.ncbi.nlm.nih.gov/18558512/). Astrocytes also express NOTCH2, where it contributes to astrocyte maturation and reactive gliosis in response to injury.

NOTCH2 in Alzheimer's Disease

The involvement of NOTCH2 in Alzheimer's disease represents an area of active investigation, with evidence pointing to both protective and pathogenic roles depending on cellular context and disease stage. Several convergent lines of evidence suggest that NOTCH2 signaling intersects with key pathological processes in AD, including amyloid-β production, tau phosphorylation, neuroinflammation, and synaptic dysfunction.

Interaction with Amyloid Precursor Protein Processing

[Notch2](/proteins/notch2-protein) and [amyloid precursor protein](/entities/app-protein) (APP) share significant structural and processing homology—both are type I transmembrane proteins that undergo sequential proteolytic cleavage by α-/β-secretases and γ-secretase [7](https://pubmed.ncbi.nlm.nih.gov/17658244/). This structural similarity extends to functional interactions, as Notch2 can be co-immunoprecipitated with APP and its cleavage products in neuronal cells.

The γ-secretase complex that generates amyloid-β from APP also cleaves Notch receptors, creating potential competition between these substrates [8](https://pubmed.ncbi.nlm.nih.gov/17148752/). In cellular models, overexpression of Notch2 has been shown to reduce amyloid-β generation, possibly through competitive inhibition of APP processing. Conversely, some studies suggest that Notch2 cleavage products can influence β-secretase (BACE1) expression, creating additional points of intersection with amyloidogenesis.

Effects on Neuronal Survival and Synaptic Plasticity

Notch2 signaling exerts neuroprotective effects in several experimental paradigms. Activation of Notch2 prevents apoptosis in cultured neurons exposed to various stresses, including oxidative stress and excitotoxicity [9](https://pubmed.ncbi.nlm.nih.gov/19443799/). These protective effects involve upregulation of anti-apoptotic proteins and activation of pro-survival signaling cascades including PI3K/Akt and NF-κB pathways.

In models of synaptic plasticity, Notch2 modulates long-term potentiation (LTP) and memory formation. Hippocampal slices from Notch2-deficient mice show deficits in LTP that are rescued by Notch2 re-expression [10](https://pubmed.ncbi.nlm.nih.gov/20668448/). The synaptic functions of Notch2 involve interactions with NMDA-type glutamate receptors and regulation of dendritic spine architecture through downstream effectors including PSD-95 and SynGAP.

Cross-talk with Wnt Signaling

A particularly relevant intersection for neurodegeneration involves cross-talk between Notch2 and Wnt/β-catenin signaling pathways. These pathways often exhibit antagonistic relationships in development and disease, with Notch2 activation suppressing Wnt-driven transcription and vice versa [11](https://pubmed.ncbi.nlm.nih.gov/20421984/). Given the well-established role of Wnt signaling dysregulation in Alzheimer's disease, this cross-talk may contribute to the progressive failure of neuroprotective mechanisms in the aging brain.

NOTCH2 in CADASIL

Unlike its complex and context-dependent role in Alzheimer's disease, NOTCH2 mutations unambiguously cause cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL)—the most common hereditary small vessel disease of the brain [12](https://pubmed.ncbi.nlm.nih.gov/15525655/). CADASIL is characterized by recurrent subcortical ischemic strokes, progressive cognitive decline, and mood disturbances, with characteristic MRI findings including white matter hyperintensities, lacunes, and cerebral microbleeds.

Over 200 distinct NOTCH2 mutations have been identified in CADASIL patients, predominantly affecting the extracellular domain and clustered in exons encoding EGF-like repeats [13](https://pubmed.ncbi.nlm.nih.gov/29154876/). These mutations cause misfolding and retention of the NOTCH2 protein in the endoplasmic reticulum, leading to reduced trafficking to the cell surface and haploinsufficiency. Vascular smooth muscle cells and pericytes, which express high levels of NOTCH2, are particularly affected, resulting in degeneration of the small vessel wall and impaired cerebral blood flow regulation.

The vascular pathology in CADASIL demonstrates the essential role of NOTCH2 in cerebrovascular homeostasis. NOTCH2 (along with NOTCH3) is required for normal development and maintenance of vascular smooth muscle cells, where it regulates expression of genes involved in contractility, extracellular matrix production, and blood pressure regulation [14](https://pubmed.ncbi.nlm.nih.gov/26255967/). Loss of NOTCH2 function in vessels leads to smooth muscle cell degeneration, basement membrane thickening, and accumulation of granular osmiotic material—all hallmark pathological features of CADASIL.

NOTCH2 in Other Neurodegenerative Conditions

Beyond AD and CADASIL, NOTCH2 has been implicated in several other neurodegenerative and neurological conditions:

Multiple Sclerosis and Demyelinating Disorders: Notch2 signaling regulates oligodendrocyte differentiation and myelination. In multiple sclerosis lesions, NOTCH2 expression is elevated in reactive astrocytes and oligodendrocyte precursors, where it may contribute to failed remyelination [15](https://pubmed.ncbi.nlm.nih.gov/19081067/). Therapeutic targeting of Notch signaling has been explored to promote remyelination, though concerns about CNS toxicity have limited clinical development.

Parkinson's Disease: Some studies have detected altered NOTCH2 expression in the substantia nigra of Parkinson's disease brains, though the significance remains unclear [16](https://pubmed.ncbi.nlm.nih.gov/23698256/). Notch2 may interact with α-synuclein pathology, as Notch2 cleavage products can influence protein aggregation pathways.

Hajdu-Cheney Syndrome: In addition to CADASIL, NOTCH2 mutations cause Hajdu-Cheney syndrome, a rare disorder characterized by bone resorption, craniofacial abnormalities, and progressive neurological symptoms including hydrocephalus and cognitive impairment [17](https://pubmed.ncbi.nlm.nih.gov/23143598/). This syndrome provides additional evidence for the importance of NOTCH2 in CNS development and function.

Therapeutic Targeting of NOTCH2

The development of NOTCH2-targeted therapeutics represents a challenging endeavor due to the pathway's essential roles in development and tissue homeostasis. Nevertheless, several therapeutic strategies have been explored:

γ-Secretase Inhibitors: These compounds prevent all Notch receptor cleavages, including NOTCH2. However, severe gastrointestinal toxicity due to inhibition of Notch1 in intestinal stem cells has limited clinical development [18](https://pubmed.ncbi.nlm.nih.gov/20090848/). Selective targeting of specific Notch receptors or development of tissue-specific delivery methods remains an active area of research.

Notch2-Specific Antibodies: Monoclonal antibodies targeting the NOTCH2 extracellular domain can block ligand binding and prevent receptor activation. Such antibodies have shown efficacy in preclinical models of CADASIL and may offer more selective targeting than γ-secretase inhibitors [19](https://pubmed.ncbi.nlm.nih.gov/28765326/).

Small Molecule Inhibitors: Novel small molecules that disrupt Notch2 transcriptional complexes or promote receptor degradation are under development. These include inhibitors of the NOTCH2-MAML interaction and compounds that enhance Notch2 ubiquitination and degradation.

Modulation of Downstream Effectors: Rather than targeting Notch2 directly, therapeutic strategies may modulate downstream effectors including Hes1, Hey2, and related transcription factors. This approach offers potential for more refined modulation of specific Notch2 functions.

Summary

NOTCH2 serves as a critical regulator of neural development, synaptic plasticity, and cerebrovascular homeostasis. Its involvement in Alzheimer's disease pathogenesis through interactions with APP processing, neuroprotection, and cross-talk with Wnt signaling highlights its potential as a therapeutic target. In CADASIL, NOTCH2 mutations directly cause the disease, providing a definitive link between Notch2 dysfunction and neurodegeneration. Continued investigation of NOTCH2 biology in the adult brain and its contributions to disease pathogenesis will be essential for developing effective neuroprotective strategies.

See Also

• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [CADASIL](/diseases/cerebral-autosomal-dominant-arteriopathy)
• [Amyloid Hypothesis](/mechanisms/amyloid-hypothesis)
• [Tau Pathology](/mechanisms/tau-pathology)
• [APP Processing](/mechanisms/app-processing)
• [Notch2 Protein](/proteins/notch2-protein)
• [Neurogenesis](/mechanisms/neurogenesis)
• [Oligodendrocyte Development](/mechanisms/oligodendrocyte-development)

External Links

• [NCBI Gene: NOTCH2](https://www.ncbi.nlm.nih.gov/gene/4853)
• [UniProt: NOTCH2](https://www.uniprot.org/uniprot/Q12983)
• [Ensembl: NOTCH2](https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000134250)
• [OMIM: NOTCH2](https://omim.org/entry/600275)
• [Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data

References

Pathway Diagram

The following diagram shows the key molecular relationships involving NOTCH2 — Notch Receptor 2 discovered through SciDEX knowledge graph analysis: